Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.
June 23, 2014
Guelph, ONTARIO—The International Fish Oil Standards™ (IFOS) Program now tests fish oil samples for radiation in response to demands for more stringent criteria than guidelines set by FDA, Health Canada and Codex.
Wiley’s Finest is the first adopter of the radiation testing category, which will now appear under the contaminants section of IFOS consumer reports and contribute to the product testing results and 5-star rating.
In the wake of Japan’s Fukushima Daiichi nuclear power plant disaster of 2011, there has been a substantial increase in consumer inquiries regarding the safety of marine products sourced from these regions, including fish oil supplements.
“Radiation testing using established FDA guidance on methods will be fully integrated into the IFOS testing program going forward so that our customers’ brands may further position themselves as premium brands to the omega-3 consumer marketplace globally," said William Rowe, founder of the IFOS Program and president and CEO of Nutrasource. “Consumers and retailers have shown an increased awareness and requirement for informed choice since the Fukushima tragedy, and this addition to the IFOS Program assists with consumer education and empowerment in everyday omega-3 supplement choices."
As of January 1, 2015, all samples submitted for testing will have radiation added to the consumer report. All customers will be transitioned from now until the end of 2014 as required. Other notable recent changes include the expansion of IFOS to include raw material suppliers, the launch of the new IFOS website and consumer blog, and the True Anisidine Value (TAV) test for flavored oils and blended formulas.
You May Also Like
9 of 10 Amazon galantamine memory supplements failed to meet label claimFeb 23, 2024
ABC reports herbal sales fell 1.9% in 2022Feb 22, 2024
Here's why creatine sales are surging this past yearFeb 21, 2024
DSHEA's 25th anniversary: Industry vets, critics respondFeb 21, 2024